---
document_datetime: 2025-01-09 09:41:57
document_pages: 34
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/gonal-f-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: gonal-f-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 21.3025783
conversion_datetime: 2025-12-21 11:53:11.383117
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## GONAL-f

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                                           |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0176/G            | This was an application for a group of variations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking | 06/01/2025                          |                                             | SmPC, Labelling and PL           | B.IV.1.a.1 (IAin) - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.IV.1.z (IB) - To reduce the number of needles in GONAL-f solution for injection in prefilled pen 900 IU/1.44 mL from |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.IV.1.z - Change of a measuring or administration device - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     | 20 to 16 needles. C.I.z (IB) - Removal of the date of first use sticker   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------------------------------------------------|
| II/0172/G | This was an application for a group of variations. B.II.b.3.c - Change in the manufacturing process of the finished or intermediate product - The product is a biological/immunological medicinal product and the change requires an assessment of comparability B.II.b.3.c - Change in the manufacturing process of the finished or intermediate product - The product is a biological/immunological medicinal product and the change requires an assessment of comparability B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits | 12/12/2024 | n/a |                                                                           |

<div style=\"page-break-after: always\"></div>

|           | during the manufacture of the finished - Addition of a new test(s) and limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     | applied product   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| IA/0175/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) A.7 - Administrative change - Deletion of manufacturing sites B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a   | 03/12/2024 | n/a | Member State      |
| WS/2744/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the | 24/10/2024 | n/a |                   |

<div style=\"page-break-after: always\"></div>

|           | approved specifications limits range for the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |     |                      |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------|
| IB/0173/G | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of | 14/08/2024 | n/a | specification limits |
| WS/2694/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure replacement or addition)                                                                                                                                         | 11/07/2024 | n/a | (including           |

<div style=\"page-break-after: always\"></div>

| IB/0171   | - Change in the specification parameters limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 03/06/2024   | n/a   | B.I.b.1.z and/or     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----------------------|
| II/0168/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change | 23/05/2024   | n/a   | outside the approved |
| WS/2655/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS Change in the specification parameters                                                                                                                                                                                                                                                                                                                                  | 11/04/2024   | n/a   | B.I.b.1.f -          |

<div style=\"page-break-after: always\"></div>

|           | and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                        |            |     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0169   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 04/04/2024 | n/a |
| IB/0166   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 27/10/2023 | n/a |
| II/0163/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other | 19/10/2023 | n/a |

<div style=\"page-break-after: always\"></div>

|           | changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                           |            |            |                        |                                                                                                                                                                           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0162/G | This was an application for a group of variations. B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation | 04/10/2023 | 27/09/2024 | SmPC, Labelling and PL |                                                                                                                                                                           |
| IA/0165   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                                | 07/09/2023 | n/a        |                        |                                                                                                                                                                           |
| II/0158   | Update of sections 4.2 and 4.4 of the SmPC in order to align the wording with current clinical practice and to remove Estradiol and follicle number thresholds                                                                                                                                                                                                                                                                                                                                                            | 31/08/2023 | 27/09/2024 | SmPC and PL            | Revision of sections 4.2 and 4.4 of the SmPC to align the posology and method of administration with the current clinical practice and evidence from clinical trials. The |

<div style=\"page-break-after: always\"></div>

|           | associated with signs of Ovarian Hyperstimulation Syndrome (OHSS), based on literature and clinical guidelines. An update of section 4.4. of the SmPC of the higher strengths (1050 IU/1.75 ml, 450 IU/0.75 mL) was included as well, in order to highlight the presence of benzyl alcohol and latex in these presentations. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to implement editorial changes to the SmPC. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |     | warning section was aligned to the lutropin alfa SmPC and current clinical practice and a reference to the GONAL-f 75 IU presentation was included in the SmPC of the higher strengths, since GONAL-f 75 IU does not contain benzyl alcohol and latex and can therefore be used as an alternative in case of hypersensitivity to these excipients. For more information, please refer to the Summary of Product Characteristics.   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0164   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 14/07/2023 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IB/0161/G | This was an application for a group of variations. B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS B.I.b.1.c - Change in the specification parameters                                        | 06/07/2023 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|           | and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                   |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0160/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 17/04/2023 | n/a |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of   |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0159/G | This was an application for a group of variations. B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/04/2023 | n/a |
| WS/2275/G | This was an application for a group of variations following a worksharing procedure according to                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 27/10/2022 | n/a |

<div style=\"page-break-after: always\"></div>

|         | Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0155 | Update of sections 4.1, 4.2, 4.3, 4.4, 4.7, 5.1, 5.2, and 6.1 of the SmPC to revise the definition of severe LH and FSH deficiency, aligning with current medical guidelines and clinical practice, to clarify follicular development as the treatment target and the use of GONAL-f in Medically Assisted Reproduction procedures for healthcare providers, and clarification of the pharmacokinetic and pharmacodynamic properties of follitropin alfa. These proposed revisions align with the CHMP positive opinion, dated 14 October 2021, for the Type II variation to update the SmPC for Pergoveris for the same indication (EMA/H/C/000714/II/0075), as Pergoveris is comprised of a fixed 2:1 ratio of follitropin alfa and lutropin alfa (r-hLH). The package leaflet is updated accordingly. In addition, the applicant has taken the opportunity to improve the Instructions for Use (IFU) layout and to implement the Medical Device Regulation in the IFU. | 21/07/2022 | 23/06/2023 | SmPC and PL | Provision of context and alignment regarding the definition of severe LH and FSH deficiency based on current medical guidelines and standards of clinical care in section 4.1 of the SmPC, as well as description of the physiologic action of Gonal-f and its use in relevant clinical settings associated with Medically Assisted Reproduction in section 4.2 of the SmPC. The section 5.1 of the SmPC is updated to include updated information on mechanism of action and pharmacodynamic effect. |

<div style=\"page-break-after: always\"></div>

|                    | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                             |            |     |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/1463/ 202110 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                                | 10/06/2022 | n/a | PRAC Recommendation - maintenance |
| IA/0157            | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                          | 24/05/2022 | n/a |                                   |
| IA/0153/G          | This was an application for a group of variations. B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits | 16/02/2022 | n/a |                                   |
| IA/0151            | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits                                                                                                                                                                                     | 03/08/2021 | n/a |                                   |
| IA/0149            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                 | 27/07/2020 | n/a |                                   |
| II/0148            | B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                  | 26/03/2020 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| II/0147   | RMP version 3.0 in order to adapt to the RMP template as per Good Pharmacovigilance Practice (GVP) Module V, rev 2, with consequential removal of important identified risks and important potential risks. The missing information on women older than 40 years was removed. C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required   | 12/03/2020   | n/a        |                                  | Submission of an updated   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------|
| II/0145/G | This was an application for a group of variations. B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                          | 12/12/2019   | 24/11/2020 | SmPC, Annex II, Labelling and PL |                            |
| IA/0146   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 25/10/2019   | n/a        |                                  |                            |

<div style=\"page-break-after: always\"></div>

| PSUSA/1463/ 201810   | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 14/06/2019   | n/a        |                                  | PRAC Recommendation - maintenance   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------|
| IB/0143              | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                       | 19/03/2019   | n/a        |                                  |                                     |
| T/0140               | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 12/07/2018   | 03/08/2018 | SmPC, Labelling and PL           |                                     |
| IB/0139              | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                                                                                                                                                                                                                              | 17/04/2018   | 03/08/2018 | SmPC                             |                                     |
| II/0138/G            | This was an application for a group of variations. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 15/06/2017   | n/a        |                                  |                                     |
| II/0136              | Update of the SmPC section 4.8 to indicate that thromboembolism can occur both in association with and separate from ovarian hyperstimulation                                                                                                                                                                                                                                                                                                                                                                    | 30/03/2017   | 01/03/2018 | SmPC, Annex II, Labelling and PL |                                     |

<div style=\"page-break-after: always\"></div>

|         | In addition, the Marketing authorisation holder (MAH) took the opportunity to update the list of local representatives in the Package Leaflet. Furthermore, the PI is brought in line with the latest QRD template version 10.0. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                   |            |     | syndrome (OHSS).   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|
| IA/0137 | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 27/02/2017 | n/a |                    |
|         | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 01/09/2016 | n/a | IA/0134/G          |

<div style=\"page-break-after: always\"></div>

| IB/0135            | B.I.a.4.f - Change to in-process tests or limits applied during the manufacture of the AS - Addition or replacement of an in-process test as a result of a safety or quality issue                                                                                                                                                                                                                             | 25/08/2016   | n/a   |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUSA/1463/ 201510 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                                                                                                 | 09/06/2016   | n/a   | PRAC Recommendation - maintenance |
| IAIN/0133          | B.II.d.1.h - Change in the specification parameters and/or limits of the finished product - Update of the dossier to comply with the provisions of an updated general monograph of the Ph. Eur. for the finished product                                                                                                                                                                                       | 30/03/2016   | n/a   |                                   |
| IB/0130/G          | This was an application for a group of variations. B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line) B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products | 01/02/2016   | n/a   |                                   |
| IA/0132/G          | This was an application for a group of variations. B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.II.e.6.b - Change in any part of the (primary)                                                                                                                             | 28/01/2016   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|         | material not in contact with the finished formulation - Change that does not affect product information                                                                |            |            |                                  | packaging product the   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------|
| IB/0129 | B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information | 11/01/2016 | 13/12/2016 | PL                               |                         |
| IG/0500 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location        | 17/11/2014 | n/a        |                                  |                         |
| IG/0461 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location        | 22/07/2014 | n/a        |                                  |                         |
| IB/0126 | B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site                                                                       | 13/05/2014 | n/a        |                                  |                         |
| IB/0125 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                         | 07/04/2014 | 09/04/2015 | SmPC, Annex II, Labelling and PL |                         |
| WS/0457 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008.                          | 18/12/2013 | n/a        |                                  |                         |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                      |            |            |    |                |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|----------------|
| IAIN/0124 | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - marking                                                              | 13/12/2013 | n/a        |    | Device with CE |
| IB/0121   | B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line) | 11/11/2013 | n/a        |    |                |
| IA/0123   | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                   | 31/10/2013 | n/a        |    |                |
| N/0118    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                  | 28/10/2013 | 09/04/2015 | PL |                |
| IB/0122   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                      | 22/10/2013 | n/a        |    |                |

<div style=\"page-break-after: always\"></div>

| IG/0361   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                               | 04/10/2013   | n/a   |                              |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|------------------------------|
| IB/0117   | B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site                                                                                                                                                                                                                                                                                                  | 22/07/2013   | n/a   |                              |
| WS/0380   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the control of the active substance B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition limits                                                                                           | 30/05/2013   | n/a   | of a new in-process test and |
| IG/0224   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                    | 11/10/2012   | n/a   |                              |
| WS/0294   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the control of the drug substance and drug product B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 20/09/2012   | n/a   |                              |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate                                                                                                                                                                                                                                                              |            |            |                        |                      |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------|
| WS/0275   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the control of the finished product B.II.d.1.z - Change in the specification parameters finished product - Other variation | 19/07/2012 | n/a        |                        | and/or limits of the |
| IB/0112   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                       | 06/01/2012 | n/a        |                        |                      |
| IB/0111   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                     | 21/11/2011 | 28/06/2012 | SmPC, Labelling and PL |                      |
| IG/0087   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                              | 18/07/2011 | n/a        |                        |                      |
| IG/0076/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the                                                                                                                              | 01/07/2011 | n/a        |                        | QPPV                 |

<div style=\"page-break-after: always\"></div>

|           | C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                               |            |            |                        |                                                                                                                               |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------|
| II/0109/G | This was an application for a group of variations. To register a new pen for presentations EU/1/95/001/033-035. To register a new site for the manufacture of the drug product. B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for biological/immunological medicinal products. | 14/04/2011 | 23/05/2011 | SmPC, Labelling and PL | To register a new pen for presentations EU/1/95/001/033- 035. To register a new site for the manufacture of the drug product. |
| IA/0110   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 23/05/2011 | n/a        |                        |                                                                                                                               |
| IG/0069   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 12/05/2011 | n/a        |                        |                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| R/0107   | Renewal of the marketing authorisation.                                                                                                                                                                                                                          | 20/05/2010   | 27/07/2010   | SmPC, Annex II, Labelling and PL   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0108   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                 | 26/04/2010   | n/a          | PL                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0106  | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                                                                                                                               | 11/09/2009   | n/a          | Annex II                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0105  | IA_01_Change in the name and/or address of the marketing authorisation holder                                                                                                                                                                                    | 11/09/2009   | n/a          | SmPC, Labelling and PL             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0102  | To amend sections 4.2 and 5.1 of the SPC in response to the CHMP assessment report (November 2008) related a FUM. The PL is amended to update the details of the Local Representative in Spain. Update of Summary of Product Characteristics and Package Leaflet | 25/06/2009   | 24/07/2009   | SmPC and PL                        | Following the Assessment of a Follow-Up Measure (FUM) the MAH was requested by the CHMP to remove from section 4.2 'Posology and Method of administration' of the SPC the sentence relating to the efficacy of the r-FSH compared to u-FSH.. During this variation application the MAH applied to modify the section 4.2 of the SPC to remove the claim that recombinant FSH (r-FSH) is more effective than urinary FSH (u-FSH). In return the statement in section 4.2 was re-worded to present the fact that lower dose of r-FSH achieves the same result as the u-FSH. This statement was re-enforced by the re-submission of the data of three clinical studies (GF 8407, 22240 and 21884) and their observations as well as newly published bibliographic data. A reference in the section 4.2 to the section 5.1 was made where more details on the results of these studies and their clinical and statistical significance are given to the prescribers. The Package Leaflet has also been amended with the |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                      |            |            |                  | contact details of the local representative for Spain.   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|----------------------------------------------------------|
| II/0104 | Change to the stability protocol for the drug substance. Change(s) to shelf-life or storage conditions                                                                               | 29/05/2009 | 11/06/2009 |                  |                                                          |
| II/0101 | Additional site for Quality Control testing of the drug substance. Change of reference standard. Change(s) to the test method(s) and/or specifications for the active substance      | 29/05/2009 | 11/06/2009 |                  |                                                          |
| IA/0103 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.) IA_05_Change in the name and/or address of a manufacturer of the finished product | 26/03/2009 | n/a        | Annex II and PL  |                                                          |
| N/0099  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                     | 20/01/2009 | n/a        | Labelling and PL |                                                          |
| IB/0100 | IB_31_a_Change to in-process tests/limits during manufacture - tightening of in-process limits                                                                                       | 19/11/2008 | n/a        |                  |                                                          |
| IA/0098 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                    | 13/10/2008 | n/a        | Annex II and PL  |                                                          |
| IA/0097 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                                                   | 13/10/2008 | n/a        | Annex II         |                                                          |
| IA/0096 | IA_04_Change in name and/or address of a manuf.                                                                                                                                      | 04/07/2008 | n/a        |                  |                                                          |

<div style=\"page-break-after: always\"></div>

|         | of the active substance (no Ph. Eur. cert. avail.) IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                      |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0093 | Quality changes                                                                                                                                                                                                                                                                                           | 30/05/2008 | 05/06/2008 |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0095 | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                                                                                                                                                               | 21/05/2008 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0094 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                                                                         | 15/04/2008 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0091 | Change(s) to shelf-life or storage conditions                                                                                                                                                                                                                                                             | 15/11/2007 | 21/12/2007 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                    |
| N/0090  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                          | 10/10/2007 | n/a        | PL                     |                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0089 | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                                                                                                                                                               | 08/08/2006 | n/a        | Labelling and PL       |                                                                                                                                                                                                                                                                                                                                                                                                    |
| IB/0088 | IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release                                                                                                                                                                                                      | 31/07/2006 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0085 | This variation relates to an update of section 4.8 of the Summary of Product Characteristics in relation to allergic reactions following CHMP request further to the assessment of the FUM 028. The Package Leaflet (section 4) was updated accordingly. Update of Summary of Product Characteristics and | 01/06/2006 | 20/07/2006 | SmPC and PL            | The MAH provided CHMP with a cumulative review of all cases of allergic reactions since 1995 and a causality assessment of the serious cases within 2 months after the renewal. The MAH have received 57 reports of allergic reactions. Out of these 10 were serious. The CHPM considered that the majority of reactions were broadly covered by the mild reactions already listed in section 4.8, |

<div style=\"page-break-after: always\"></div>

|         | Package Leaflet                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                                  | but that some additions were necessary and the SPC has updated (section 4.8) to reflect these changes. The Package Leaflet (section 4) was updated accordingly.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0081 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 01/06/2006 | 26/06/2006 | Annex II                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0080 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 01/06/2006 | 07/06/2006 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0084 | This variation concerns an update of section 4.8 of the Summary of Product Characteristics to add varicocele and injection site reaction in men following the assessment of long term data from male population treated for isolated hypogonadotrophic hypogonadism. These adverse reactions were also added to section 4 of the Package Leaflet (PL). In addition, the MAH updated section 3 of the PL for pre-filled pen to improve its safe use, and updated the Annexes according to the current version 7 of the QRD template. Update of Summary of Product Characteristics, Labelling and Package Leaflet | 23/03/2006 | 10/05/2006 | SmPC, Annex II, Labelling and PL | The CHMP recommended that varicocele in males should be added to the section 4.8 of the SPC as \"common\" adverse reactions occurring in >1/100 to <1/10 clinical trial cases (there were 7 cases of varicocele from 6 patients including one serious case) in clinical trials with GONAL-f. The MAH was also requested to add injection site reaction as a \"very common\" (>1/10) adverse reaction in men, as this reaction was only described as occurring in females in the section 4.8 of the SPC. These adverse reactions were also added to section 4 of the Package Leaflet. The MAH also took this opportunity to include a sentence in the section 3 of the PIL of the GONAL-f pre-filled pen to improve its safe use, and to update the Annexes according to the current version 7 of the QRD template. |
| IB/0086 | IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 08/05/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0079 | Change(s) to the manufacturing process for the finished product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 27/04/2006 | 03/05/2006 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0083 | Change(s) to the manufacturing process for the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/02/2006 | 28/02/2006 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|         | finished product                                                                                                                                                                                                   |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0078  | Renewal of the marketing authorisation.                                                                                                                                                                            | 27/07/2005 | 19/10/2005 | SmPC, Annex II, Labelling and PL | test because this won't work either, although Kevin says otherwise.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0076 | IB_37_a_Change in the specification of the finished product - tightening of specification limits                                                                                                                   | 11/05/2005 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0072 | Update of the sections 4.4, 6.5, 6.6 of the Summary of Product Characteristics (SPC) and sections 2, 3, 6 of the Package Leaflet (PL). Update of Summary of Product Characteristics, Labelling and Package Leaflet | 17/03/2005 | 25/04/2005 | SmPC, Labelling and PL           | The Marketing Authorisation Holder (MAH) has applied for an update of section 4.4 of the Summary of Product Characteristics (SPC) and section 2 of the Package Leaflet (PL) to include a warning for patients with porphyria or a family history of porphyria in compliance with the CHMP conclusions on the 12th PSUR. The MAH also applied for descriptive changes of the crimp cap in section 6.5 of the SPC for the pre-filled pen presentation and proposed to clarify administration instructions of multidose presentations for self-users: the MAH therefore applied for changes to sections 4.4, 6.6 of the SPC, sections 2 and 3 of the PL and section 5 of the outer packaging for the multidose presentations. In addition the contact details of the Danish and Greek local representatives in section 6 of the PL have been updated. |
| IA/0077 | IA_09_Deletion of manufacturing site                                                                                                                                                                               | 14/04/2005 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IB/0075 | IB_37_a_Change in the specification of the finished product - tightening of specification limits IB_38_b_Change in test procedure of finished                                                                      | 22/03/2005 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|         | product - minor change, biol. active subst./excipient                                                |            |            |                        |
|---------|------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0071 | IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release | 05/01/2005 | n/a        |                        |
| IA/0070 | IA_28_Change in any part of primary packaging material not in contact with finished product          | 16/12/2004 | n/a        |                        |
| IA/0069 | IA_16_b_Submission of new TSE certificate relating to active substance - other substances            | 16/12/2004 | n/a        |                        |
| IA/0068 | IA_28_Change in any part of primary packaging material not in contact with finished product          | 16/12/2004 | n/a        |                        |
| IA/0067 | IA_05_Change in the name and/or address of a manufacturer of the finished product                    | 15/12/2004 | n/a        |                        |
| IA/0066 | IA_05_Change in the name and/or address of a manufacturer of the finished product                    | 06/10/2004 | n/a        |                        |
| IB/0065 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                           | 29/06/2004 | n/a        | SmPC                   |
| IB/0064 | IB_20_c_Change in test procedure for an excipient - other changes                                    | 24/05/2004 | n/a        |                        |
| X/0059  | X-3-iv_Change or addition of a new pharmaceutical form                                               | 25/09/2003 | 23/02/2004 | SmPC, Labelling and PL |
| II/0060 | New presentation(s)                                                                                  | 25/09/2003 | 14/01/2004 | SmPC, Labelling and    |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                      |            |            | PL                     |
|---------|------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| I/0062  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process       | 10/10/2003 | 23/10/2003 |                        |
| I/0061  | 31_Change in container shape                                                                         | 10/10/2003 | 10/10/2003 | SmPC                   |
| I/0063  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process       | 20/08/2003 | 22/09/2003 |                        |
| N/0058  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)     | 13/02/2003 | 24/03/2003 | PL                     |
| I/0057  | 20_Extension of shelf-life as foreseen at time of authorisation                                      | 22/01/2003 | 22/01/2003 |                        |
| I/0056  | 12a_Change in specification of starting material/intermediate used in manuf. of the active substance | 18/12/2002 | 20/12/2002 |                        |
| I/0055  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process       | 04/10/2002 | 11/10/2002 |                        |
| I/0053  | 02_Change in the name of the medicinal product (either invented name of common name)                 | 21/08/2002 | 02/10/2002 | SmPC, Labelling and PL |
| II/0049 | Change(s) to the test method(s) and/or specifications for the active substance                       | 19/09/2002 | 27/09/2002 |                        |
| I/0054  | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance       | 20/08/2002 | 10/09/2002 |                        |

<div style=\"page-break-after: always\"></div>

| I/0051   | 24_Change in test procedure of active substance 25_Change in test procedures of the medicinal product                                                                                                                                                                                                                       | 18/07/2002   | 19/07/2002   |                        |                                                                                                                                                                                                                                                                                                                                                               |
|----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| I/0052   | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                                                                                                                              | 16/07/2002   | 17/07/2002   |                        |                                                                                                                                                                                                                                                                                                                                                               |
| I/0050   | 01_Change in the name of a manufacturer of the medicinal product                                                                                                                                                                                                                                                            | 09/07/2002   | 09/07/2002   |                        |                                                                                                                                                                                                                                                                                                                                                               |
| II/0048  | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                                                              | 27/06/2002   | 28/06/2002   |                        |                                                                                                                                                                                                                                                                                                                                                               |
| II/0040  | Change to replace the currently registered ampoules containing the water for injections by vials to improve suitability of the product for patients. Change(s) to container                                                                                                                                                 | 13/12/2001   | 07/06/2002   | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                               |
| II/0039  | Addition of methionine and polysorbate 20 as excipients, to improve the stability of the product and to reduce the rate of oxidation. Change in formulation                                                                                                                                                                 | 13/12/2001   | 07/06/2002   | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                               |
| II/0038  | Change to formulate and fill the medicinal product by mass (based on protein) rather than by definition of activity (IU) (based on bioassay). As a result, the quantity of active substance and strength are defined in mass units, where Gonal-F 37.5IU, 75 IU, 150 IU, and 600 IU/ml are expressed as Gonal-F 2.5, 5, and | 13/12/2001   | 07/06/2002   | SmPC, Labelling and PL | Based on the provided data, a conversion factor of 75 IU (target bioavailability) to 5.46 micrograms was determined. The quality of the product is not affected by this variation. Gonal-F is dual labelled: mass as the primary unit and International Units. It is considered necessary to include both mass and IU on product information/labels, at least |

<div style=\"page-break-after: always\"></div>

|         | 10 micrograms, and 40 micrograms/ml respectively. Change(s) to the manufacturing process for the finished product                                                                                                       |            |            |                        | until users are familiarised with the new units.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0037 | Replacement of the currently registered ampoule containing the Gonal-F powder with a vial presentation for the Gonal-F 37.5 IU presentations to improve suitability of the product for patients. Change(s) to container | 13/12/2001 | 07/06/2002 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| X/0041  | Addition of new presentations with the solvent presented in prefilled syringes. X-3-iv_Change or addition of a new pharmaceutical form                                                                                  | 13/12/2001 | 06/06/2002 | SmPC, Labelling and PL | The new presentations of the solvent consists of 1.1 ml sterilised water for injections (Ph.Eur.) in pre-filled syringes (Type I Ph.Eur. colourless glass). Pack sizes are: 1, 5, and 10 pre-filled syringes. Except for a limited number of points, which can be addressed as part of post- authorisation commitments, the quality of these new presentation is considered to be acceptable when used in accordance with the conditions defined in the SPC. Physicochemical and biological aspects relevant to the uniform clinical performance of the new presentations have been investigated and are controlled in a satisfactory way. Viral safety and batch-to-batch consistency has been documented and the relevant test will be performed according to the agreed specifications. |
| II/0044 | New presentation(s)                                                                                                                                                                                                     | 13/12/2001 | 06/06/2002 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| I/0047  | 20_Extension of shelf-life as foreseen at time of authorisation                                                                                                                                                         | 11/01/2002 | 19/02/2002 | SmPC                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

| I/0046   | 23_Change in storage conditions                                                                      | 13/11/2001   | 28/01/2002   | SmPC, Labelling and PL   |
|----------|------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| I/0045   | 03_Change in the name and/or address of the marketing authorisation holder                           | 21/09/2001   | 07/11/2001   | SmPC, Labelling and PL   |
| II/0030  | Update of or change(s) to the pharmaceutical documentation                                           | 19/09/2001   | 24/09/2001   |                          |
| I/0036   | 17_Change in specification of the medicinal product                                                  | 20/07/2001   | n/a          |                          |
| I/0035   | 25_Change in test procedures of the medicinal product                                                | 20/07/2001   | n/a          |                          |
| I/0034   | 20_Extension of shelf-life as foreseen at time of authorisation                                      | 17/04/2001   | 20/07/2001   | SmPC                     |
| I/0033   | 10a_Addition or replacement of measuring device for oral liquid dosage forms and other dosage forms  | 17/05/2001   | 20/07/2001   | SmPC, Labelling and PL   |
| I/0032   | 01_Change following modification(s) of the manufacturing authorisation(s)                            | 09/04/2001   | 20/07/2001   |                          |
| I/0043   | 12a_Change in specification of starting material/intermediate used in manuf. of the active substance | 18/06/2001   | 06/07/2001   |                          |
| II/0027  | Update of Summary of Product Characteristics and Package Leaflet                                     | 01/03/2001   | 20/06/2001   | SmPC, Labelling and      |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                  |            |            | PL                               |                  |
|---------|--------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------|
| II/0026 | Extension of Indication                                                                          | 01/03/2001 | 20/06/2001 | SmPC and PL                      |                  |
| I/0031  | 20_Extension of shelf-life as foreseen at time of authorisation                                  | 12/01/2001 | 05/03/2001 | SmPC                             |                  |
| II/0028 | Change(s) to the test method(s) and/or specifications for the finished product                   | 25/01/2001 | 30/01/2001 |                                  |                  |
| X/0022  | X-3-iii_Addition of new strength                                                                 | 21/09/2000 | 29/01/2001 | SmPC, Annex II, Labelling and PL |                  |
| R/0025  | Renewal of the marketing authorisation.                                                          | 21/09/2000 | 29/12/2000 | SmPC, Annex II, Labelling and PL |                  |
| I/0029  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process   | 15/12/2000 | n/a        |                                  |                  |
| I/0020  | 12_Minor change of manufacturing process of the                                                  | 29/06/2000 | n/a        |                                  | active substance |
| I/0023  | 01_Change following modification(s) of the manufacturing authorisation(s)                        | 07/01/2000 | 16/03/2000 | Annex II and PL                  |                  |
| N/0024  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 07/01/2000 | 16/03/2000 | PL                               |                  |
| N/0021  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 14/10/1999 | 08/12/1999 | PL                               |                  |

<div style=\"page-break-after: always\"></div>

|         | 16_Change in the batch size of finished product 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process   | 24/06/1999   | 02/09/1999   |                                  | I/0019     |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|------------|
| X/0015  | X-3-iii_Addition of new strength                                                                                                                 | 25/02/1999   | 18/06/1999   | SmPC, Annex II, Labelling and PL |            |
| II/0018 | Update of Summary of Product Characteristics and Package Leaflet                                                                                 | 25/02/1999   | 16/06/1999   | SmPC, Labelling and PL           |            |
| II/0017 | Extension of                                                                                                                                     | 25/02/1999   | 16/06/1999   | SmPC and PL                      | Indication |
| II/0014 | Change(s) to the test method(s) and/or specifications for the finished product                                                                   | 22/07/1998   | 02/09/1998   |                                  |            |
| II/0010 | Change(s) to the test method(s) and/or specifications for the active substance                                                                   | 22/07/1998   | 02/09/1998   |                                  |            |
| I/0009  | 14_Change in specifications of active substance 24_Change in test procedure of active substance                                                  | 22/07/1998   | 02/09/1998   |                                  |            |
| N/0016  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                 | 05/06/1998   | 17/07/1998   | PL                               |            |
| I/0011  | 24_Change in test procedure of active substance                                                                                                  | 27/05/1998   | n/a          |                                  |            |
| I/0013  | 24_Change in test procedure of active substance                                                                                                  | 17/05/1998   | n/a          |                                  |            |
| I/0012  | 24_Change in test procedure of active substance 25_Change in test procedures of the medicinal product                                            | 17/05/1998   | n/a          |                                  |            |

<div style=\"page-break-after: always\"></div>

| I/0008   | 24_Change in test procedure of active substance                           | 17/12/1997   | n/a        |                        |                  |
|----------|---------------------------------------------------------------------------|--------------|------------|------------------------|------------------|
| I/0007   | 24_Change in test procedure of active substance                           | 17/12/1997   | n/a        |                        |                  |
| I/0006   | 01_Change following modification(s) of the manufacturing authorisation(s) | 08/07/1997   | 30/09/1997 | SmPC, Labelling and PL |                  |
| I/0005   | 12_Minor change of manufacturing process of the active substance          | 23/07/1997   | n/a        |                        |                  |
| I/0003   | 20_Extension of shelf-life as foreseen at time of authorisation           | 16/10/1996   | 20/01/1997 | SmPC                   |                  |
| I/0004   | 12_Minor change of manufacturing process of the                           | 12/09/1996   | n/a        |                        | active substance |
| II/0001  | Extension of Indication                                                   | 14/02/1996   | 28/06/1996 | SmPC, Labelling and PL |                  |
| I/0002   | 15_Minor changes in manufacture of the medicinal                          | 02/02/1996   | n/a        |                        | product          |